8
Oct
2024
Shenzhen Haorui Pharmatech Co., Ltd
Exhibitor at CPHI Milan 2024 stand 24C73, Fine Chemicals
About Us
Categories
-
CN
-
2015On CPHI since
-
100 - 249Employees
Company types
Event information
CPHI Milan 2024
-
08 Oct 2024 - 10 Oct 2024
-
Fiera Milano, Italy
-
Visit us at stand 24C73, Fine Chemicals
Products Featured at CPHI Milan 2024
-
Product Docetaxel anhydrous
We offer a wide range of API products which includes Docetaxel anhydrous. It belongs to oncology category. Therapeutic category: antineoplastic. Contact us for more information.
Other products:Amisulpride,Desvenlafaxine Succinate,Neostigmine methylsulfate
Teicoplanin,Daptomycin,Minocycline HCl... -
Product Dasatinib anhydrous/monohydrate
We offer a wide range of API products which include Dasatinib monohydrate. It belongs to oncology category. Therapeutic category: molecular targeted. Contact us for more information. -
Product Irinotecan HCl
Shenzhen Haorui Industrial Dev. Co., Ltd. offers a wide range of API products which includes Irinotecan HCl. It belongs to oncology category. Therapeutic category: antineoplastic. Contact us for more information. -
Product Granisetron Base/Hydrochloride
We provide high quality Granisetron with DMF. -
Product Flumazenil
Shenzhen Haorui Industrial Dev. Co., Ltd. offers a wide range of products which includes Flumazenil. It belongs to API category. Therapeutic category: benzodiazepine. Contact us for more information.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance